« Back
Home /
Brigatinib

Brigatinib

Manufacturer	MedChem Express
Category	Oncology Neuroscience Molecular Targets for Neuroscience Neural Signaling Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Bladder Cancer Nervous System Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10mM*1 mL
Item no.	HY-12857-10mM
Targets	ALK
CASRN	1197953-54-0
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC50 of 0.6 nM. Brigatinib can be used for research of NSCLC[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	584.09
Clinical_Information	Launched
Manufacturers Research_Area	Cancer
Solubility	DMSO : 2 mg/mL (ultrasonic)\|Ethanol : 10 mg/mL (ultrasonic; warming)
Pathway	Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mM*1 mL

available

Request delivery time